Show/Hide Menu
Hide/Show Apps
anonymousUser
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Videos
Videos
Thesis submission
Thesis submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Contact us
Contact us
RNA-biology ruling cancer progression? Focus on 3 ' UTRs and splicing
Date
2020-09-01
Author
Erson Bensan, Ayşe Elif
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
12
views
0
downloads
Cite This
The protein-coding regions of mRNAs have the information to make proteins and hence have been at the center of attention for understanding altered protein functions in disease states, including cancer. Indeed, the discovery of genomic alterations and driver mutations that change protein levels and/or activity has been pivotal in our understanding of cancer biology. However, to better understand complex molecular mechanisms that are deregulated in cancers, we also need to look at non-coding parts of mRNAs, including 3 ' UTRs (untranslated regions), which control mRNA stability, localization, and translation efficiency. Recently, these rather overlooked regions of mRNAs are gaining attention as mounting evidence provides functional links between 3 ' UTRs, protein functions, and cancer-related molecular mechanisms. Here, roles of 3 ' UTRs in cancer biology and mechanisms that result in cancer-specific 3 '-end isoform variants will be reviewed. An increased appreciation of 3 ' UTRs may help the discovery of new ways to explain as of yet unknown oncogene activation and tumor suppressor inactivation cases in cancers, and provide new avenues for diagnostic and therapeutic applications.
Subject Keywords
Cancer research
,
Oncology
,
mRNA
,
UTR
,
Splicing
,
Polyadenylation
,
microRNA
,
RNA-binding protein
,
Mutation
,
Structural variation
,
TP53
,
MYC
,
PD-L1
,
BRAF
URI
https://hdl.handle.net/11511/38697
Journal
CANCER AND METASTASIS REVIEWS
DOI
https://doi.org/10.1007/s10555-020-09884-9
Collections
Department of Biology, Article
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
A. E. Erson Bensan, “RNA-biology ruling cancer progression? Focus on 3 ′ UTRs and splicing,”
CANCER AND METASTASIS REVIEWS
, vol. 39, no. 3, pp. 887–901, 2020, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/38697.